{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T18:41:58Z","timestamp":1794336118588,"version":"4.9.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82405296, 82274483, 82305158"],"award-info":[{"award-number":["82405296, 82274483, 82305158"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Ulcerative colitis (UC) is a chronic inflammatory disorder marked by epithelial barrier disruption and persistent intestinal inflammation. Despite extensive research, its complex etiology continues to pose therapeutic challenges. Ferroptosis, an iron-dependent form of regulated cell death driven by lipid peroxidation, has recently been implicated in UC pathogenesis. Additionally, the gut microbiota and its metabolites play a pivotal role in maintaining intestinal homeostasis and barrier integrity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>\n                      This study aimed to investigate the therapeutic potential of a phytotherapeutic agent QCHS to alleviate UC by modulating ferroptosis and the microbiota-metabolome axis, with a particular focus on the role of\n                      <jats:italic>Lactobacillus gasseri<\/jats:italic>\n                      (\n                      <jats:italic>L. gasseri<\/jats:italic>\n                      ).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A DSS-induced UC mouse model was used to evaluate QCHS efficacy. Gut microbial composition and metabolomic alterations were analyzed via 16S rDNA sequencing and UHPLC-MS\/MS.\n                      <jats:italic>L. gasseri<\/jats:italic>\n                      was cultured in vitro to assess the impact of QCHS on its growth. RSL3-induced cell death was modeled in NCM-460 cells and ferroptosis-related changes were examined using transmission electron microscopy, immunohistochemistry, quantitative PCR, and Western blotting.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      QCHS significantly mitigated DSS-induced ferroptosis in colonic tissues, with\n                      <jats:italic>L. gasseri<\/jats:italic>\n                      identified as a key mediator. Notably,\n                      <jats:italic>L. gasseri<\/jats:italic>\n                      was found to act as a novel ferroptosis inhibitor. In vitro studies confirmed that\n                      <jats:italic>L. gasseri<\/jats:italic>\n                      suppressed RSL3-induced ferroptosis in NCM-460 cells via activation of the GSH\/GPX4 pathway.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      This study provides compelling evidence for the regulatory role of QCHS on the microbiota-metabolome axis and ferroptosis in UC. It also uncovers a novel function of\n                      <jats:italic>L. gasseri<\/jats:italic>\n                      as a ferroptosis inhibitor, offering promising insights into microbiota-targeted and ferroptosis-modulating therapeutic strategies for UC.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s13020-025-01317-5","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T02:52:23Z","timestamp":1769395943000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Qing-Chang-Hua-Shi granule ameliorates experimental colitis by modulating Lactobacillus gasseri-mediated ferroptosis metabolic pathway"],"prefix":"10.1186","volume":"21","author":[{"given":"Cheng","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Au","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuguang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Di","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongchang","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilin","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,26]]},"reference":[{"issue":"7","key":"1317_CR1","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/j.mayocp.2019.01.018","volume":"94","author":"JD Feuerstein","year":"2019","unstructured":"Feuerstein JD, Moss AC, Farraye FA. Ulcerative colitis. Mayo Clin Proc. 2019;94(7):1357\u201373.","journal-title":"Mayo Clin Proc"},{"issue":"18","key":"1317_CR2","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMra1102942","volume":"365","author":"S Danese","year":"2011","unstructured":"Danese S, Fiocchi C. Ulcerative colitis. N Engl J Med. 2011;365(18):1713\u201325.","journal-title":"N Engl J Med"},{"issue":"1","key":"1317_CR3","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.mayocp.2018.09.013","volume":"94","author":"GP Ramos","year":"2019","unstructured":"Ramos GP, Papadakis KA. Mechanisms of disease: inflammatory bowel diseases. Mayo Clin Proc. 2019;94(1):155\u201365.","journal-title":"Mayo Clin Proc"},{"issue":"9","key":"1317_CR4","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/s41575-020-0326-4","volume":"17","author":"JV Patankar","year":"2020","unstructured":"Patankar JV, Becker C. Cell death in the gut epithelium and implications for chronic inflammation. Nat Rev Gastroenterol Hepatol. 2020;17(9):543\u201356.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"10","key":"1317_CR5","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrgastro.2017.88","volume":"14","author":"J Ni","year":"2017","unstructured":"Ni J, Wu GD, Albenberg L, Tomov VT. Gut microbiota and IBD: causation or correlation? Nat Rev Gastroenterol Hepatol. 2017;14(10):573\u201384.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"1317_CR6","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1053\/j.gastro.2020.09.056","volume":"160","author":"M Lee","year":"2021","unstructured":"Lee M, Chang EB. Inflammatory bowel diseases (IBD) and the microbiome-searching the crime scene for clues. Gastroenterology. 2021;160(2):524\u201337.","journal-title":"Gastroenterology"},{"issue":"4","key":"1317_CR7","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41575-019-0258-z","volume":"17","author":"A Lavelle","year":"2020","unstructured":"Lavelle A, Sokol H. Gut microbiota-derived metabolites as key actors in inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2020;17(4):223\u201337.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1317_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.658354","volume":"12","author":"N Gasaly","year":"2021","unstructured":"Gasaly N, de Vos P, Hermoso MA. Impact of bacterial metabolites on gut barrier function and host immunity: a focus on bacterial metabolism and its relevance for intestinal inflammation. Front Immunol. 2021;12:658354.","journal-title":"Front Immunol"},{"issue":"7790","key":"1317_CR9","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s41586-019-1865-0","volume":"577","author":"X Song","year":"2020","unstructured":"Song X, Sun X, Oh SF, Wu M, Zhang Y, Zheng W, et al. Microbial bile acid metabolites modulate gut RORgamma(+) regulatory T cell homeostasis. Nature. 2020;577(7790):410\u20135.","journal-title":"Nature"},{"issue":"1","key":"1317_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms7734","volume":"6","author":"L Macia","year":"2015","unstructured":"Macia L, Tan J, Vieira AT, Leach K, Stanley D, Luong S, et al. Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome. Nat Commun. 2015;6(1):1\u201315.","journal-title":"Nat Commun"},{"issue":"8","key":"1317_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/app13084726","volume":"13","author":"C Thoda","year":"2023","unstructured":"Thoda C, Touraki M. Immunomodulatory properties of probiotics and their derived bioactive compounds. Appl Sci. 2023;13(8):4726.","journal-title":"Appl Sci"},{"issue":"1","key":"1317_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11306-017-1311-y","volume":"14","author":"EA Scoville","year":"2018","unstructured":"Scoville EA, Allaman MM, Brown CT, Motley AK, Horst SN, Williams CS, et al. Alterations in lipid, amino acid, and energy metabolism distinguish Crohn\u2019s disease from ulcerative colitis and control subjects by serum metabolomic profiling. Metabolomics. 2018;14(1):17.","journal-title":"Metabolomics"},{"issue":"3","key":"1317_CR13","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1097\/MIB.0b013e3182810122","volume":"19","author":"R Marion-Letellier","year":"2013","unstructured":"Marion-Letellier R, Savoye G, Beck PL, Panaccione R, Ghosh S. Polyunsaturated fatty acids in inflammatory bowel diseases: a reappraisal of effects and therapeutic approaches. Inflamm Bowel Dis. 2013;19(3):650\u201361.","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"1317_CR14","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.cmet.2020.10.011","volume":"32","author":"J Zheng","year":"2020","unstructured":"Zheng J, Conrad M. The metabolic underpinnings of ferroptosis. Cell Metab. 2020;32(6):920\u201337.","journal-title":"Cell Metab"},{"issue":"14","key":"1317_CR15","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","volume":"185","author":"BR Stockwell","year":"2022","unstructured":"Stockwell BR. Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications. Cell. 2022;185(14):2401\u201321.","journal-title":"Cell"},{"issue":"9","key":"1317_CR16","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1080\/15548627.2020.1810918","volume":"17","author":"X Chen","year":"2021","unstructured":"Chen X, Li J, Kang R, Klionsky DJ, Tang D. Ferroptosis: machinery and regulation. Autophagy. 2021;17(9):2054\u201381.","journal-title":"Autophagy"},{"issue":"1-2","key":"1317_CR17","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"WS Yang","year":"2014","unstructured":"Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS, et al. Regulation of ferroptotic cancer cell death by GPX4. Cell. 2014;156(1\u20132):317\u201331.","journal-title":"Cell"},{"issue":"4","key":"1317_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03559-1","volume":"12","author":"S Xu","year":"2021","unstructured":"Xu S, He Y, Lin L, Chen P, Chen M, Zhang S. The emerging role of ferroptosis in intestinal disease. Cell Death Dis. 2021;12(4):289.","journal-title":"Cell Death Dis"},{"issue":"2","key":"1317_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2299-1","volume":"11","author":"M Xu","year":"2020","unstructured":"Xu M, Tao J, Yang Y, Tan S, Liu H, Jiang J, et al. Ferroptosis involves in intestinal epithelial cell death in ulcerative colitis. Cell Death Dis. 2020;11(2):86.","journal-title":"Cell Death Dis"},{"issue":"11","key":"1317_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-022-04594-7","volume":"79","author":"Y Chen","year":"2022","unstructured":"Chen Y, Yan W, Chen Y, Zhu J, Wang J, Jin H, et al. SLC6A14 facilitates epithelial cell ferroptosis via the C\/EBP\u03b2-PAK6 axis in ulcerative colitis. Cell Mol Life Sci. 2022;79(11):563.","journal-title":"Cell Mol Life Sci"},{"issue":"10","key":"1317_CR21","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.dld.2021.02.011","volume":"53","author":"S Dong","year":"2021","unstructured":"Dong S, Lu Y, Peng G, Li J, Li W, Li M, et al. Furin inhibits epithelial cell injury and alleviates experimental colitis by activating the Nrf2-Gpx4 signaling pathway. Dig Liver Dis. 2021;53(10):1276\u201385.","journal-title":"Dig Liver Dis"},{"issue":"2","key":"1317_CR22","first-page":"181","volume":"15","author":"Y Yang","year":"2023","unstructured":"Yang Y, Wang Y, Zhao L, Wang F, Li M, Wang Q, et al. Chinese herbal medicines for treating ulcerative colitis via regulating gut microbiota-intestinal immunity axis. Chin Herb Med. 2023;15(2):181\u2013200.","journal-title":"Chin Herb Med"},{"key":"1317_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111580","volume":"139","author":"H Shen","year":"2021","unstructured":"Shen H, Zhang S, Zhao W, Ren S, Ke X, Gu Q, et al. Randomised clinical trial: efficacy and safety of Qing-Chang-Hua-Shi granules in a multicenter, randomized, and double-blind clinical trial of patients with moderately active ulcerative colitis. Biomed Pharmacother. 2021;139:111580.","journal-title":"Biomed Pharmacother"},{"key":"1317_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.108967","volume":"116","author":"L Zhu","year":"2019","unstructured":"Zhu L, Dai LM, Shen H, Gu PQ, Zheng K, Liu YJ, et al. Qing Chang Hua Shi granule ameliorate inflammation in experimental rats and cell model of ulcerative colitis through MEK\/ERK signaling pathway. Biomed Pharmacother. 2019;116:108967.","journal-title":"Biomed Pharmacother"},{"key":"1317_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154452","volume":"107","author":"C Cheng","year":"2022","unstructured":"Cheng C, Hu J, Li Y, Ji Y, Lian Z, Au R, et al. Qing-Chang-Hua-Shi granule ameliorates DSS-induced colitis by activating NLRP6 signaling and regulating Th17\/Treg balance. Phytomedicine. 2022;107:154452.","journal-title":"Phytomedicine"},{"issue":"50","key":"1317_CR26","doi-asserted-by":"publisher","first-page":"15240","DOI":"10.1021\/acs.jafc.1c06292","volume":"69","author":"C Cheng","year":"2021","unstructured":"Cheng C, Zhang W, Zhang C, Ji P, Wu X, Sha Z, et al. Hyperoside ameliorates DSS-induced colitis through MKRN1-mediated regulation of PPAR\u03b3 signaling and Th17\/Treg balance. J Agric Food Chem. 2021;69(50):15240\u201351.","journal-title":"J Agric Food Chem"},{"issue":"10114","key":"1317_CR27","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","volume":"390","author":"SC Ng","year":"2017","unstructured":"Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390(10114):2769\u201378.","journal-title":"Lancet"},{"issue":"10114","key":"1317_CR28","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1016\/S0140-6736(17)32669-7","volume":"390","author":"MA Kamm","year":"2017","unstructured":"Kamm MA. Rapid changes in epidemiology of inflammatory bowel disease. Lancet. 2017;390(10114):2741\u20132.","journal-title":"Lancet"},{"issue":"4","key":"1317_CR29","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1093\/ecco-jcc\/jjv223","volume":"10","author":"M Alipour","year":"2016","unstructured":"Alipour M, Zaidi D, Valcheva R, Jovel J, Mart\u00ednez I, Sergi C, et al. Mucosal barrier depletion and loss of bacterial diversity are primary abnormalities in paediatric ulcerative colitis. J Crohns Colitis. 2016;10(4):462\u201371.","journal-title":"J Crohns Colitis"},{"issue":"1","key":"1317_CR30","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.chom.2021.11.001","volume":"30","author":"M Alexander","year":"2022","unstructured":"Alexander M, Ang QY, Nayak RR, Bustion AE, Sandy M, Zhang B, et al. Human gut bacterial metabolism drives Th17 activation and colitis. Cell Host Microbe. 2022;30(1):17-30.e9.","journal-title":"Cell Host Microbe"},{"key":"1317_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2021.105383","volume":"163","author":"S Kumar","year":"2022","unstructured":"Kumar S, Kumar A. Microbial pathogenesis in inflammatory bowel diseases. Microb Pathog. 2022;163:105383.","journal-title":"Microb Pathog"},{"key":"1317_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.733992","volume":"12","author":"P Qiu","year":"2022","unstructured":"Qiu P, Ishimoto T, Fu L, Zhang J, Zhang Z, Liu Y. The gut microbiota in inflammatory bowel disease. Front Cell Infect Microbiol. 2022;12:733992.","journal-title":"Front Cell Infect Microbiol"},{"issue":"7","key":"1317_CR33","doi-asserted-by":"publisher","first-page":"825","DOI":"10.4014\/jmb.2203.03022","volume":"32","author":"S Yu","year":"2022","unstructured":"Yu S, Sun Y, Shao X, Zhou Y, Yu Y, Kuai X, et al. Leaky gut in IBD: intestinal barrier-gut microbiota interaction. J Microbiol Biotechnol. 2022;32(7):825\u201334.","journal-title":"J Microbiol Biotechnol"},{"issue":"1","key":"1317_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-018-0483-8","volume":"25","author":"LC Yu","year":"2018","unstructured":"Yu LC. Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis. J Biomed Sci. 2018;25(1):79.","journal-title":"J Biomed Sci"},{"issue":"7746","key":"1317_CR35","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41586-019-0992-y","volume":"567","author":"K Parikh","year":"2019","unstructured":"Parikh K, Antanaviciute A, Fawkner-Corbett D, Jagielowicz M, Aulicino A, Lagerholm C, et al. Colonic epithelial cell diversity in health and inflammatory bowel disease. Nature. 2019;567(7746):49\u201355.","journal-title":"Nature"},{"key":"1317_CR36","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aao4755","author":"NA Scott","year":"2018","unstructured":"Scott NA, Andrusaite A, Andersen P, Lawson M, Alcon-Giner C, Leclaire C, et al. Antibiotics induce sustained dysregulation of intestinal T cell immunity by perturbing macrophage homeostasis. Sci Transl Med. 2018. https:\/\/doi.org\/10.1126\/scitranslmed.aao4755.","journal-title":"Sci Transl Med"},{"issue":"4","key":"1317_CR37","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.cell.2016.10.020","volume":"167","author":"M Schirmer","year":"2016","unstructured":"Schirmer M, Smeekens SP, Vlamakis H, Jaeger M, Oosting M, Franzosa EA, et al. Linking the human gut microbiome to inflammatory cytokine production capacity. Cell. 2016;167(4):1125-1136.e8.","journal-title":"Cell"},{"key":"1317_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.886061","volume":"12","author":"Y Zhu","year":"2022","unstructured":"Zhu Y, Xu Y, Wang X, Rao L, Yan X, Gao R, et al. Probiotic cocktail alleviates intestinal inflammation through improving gut microbiota and metabolites in colitis mice. Front Cell Infect Microbiol. 2022;12:886061.","journal-title":"Front Cell Infect Microbiol"},{"issue":"3","key":"1317_CR39","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s10787-019-00595-4","volume":"27","author":"I Bjarnason","year":"2019","unstructured":"Bjarnason I, Sission G, Hayee B. A randomised, double-blind, placebo-controlled trial of a multi-strain probiotic in patients with asymptomatic ulcerative colitis and Crohn\u2019s disease. Inflammopharmacology. 2019;27(3):465\u201373.","journal-title":"Inflammopharmacology"},{"key":"1317_CR40","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.copbio.2017.08.004","volume":"49","author":"DD Heeney","year":"2018","unstructured":"Heeney DD, Gareau MG, Marco ML. Intestinal Lactobacillus in health and disease, a driver or just along for the ride? Curr Opin Biotechnol. 2018;49:140\u20137.","journal-title":"Curr Opin Biotechnol"},{"issue":"5","key":"1317_CR41","doi-asserted-by":"publisher","first-page":"3546","DOI":"10.1016\/j.sjbs.2022.02.044","volume":"29","author":"S Selvamani","year":"2022","unstructured":"Selvamani S, Mehta V, Ali El Enshasy H, Thevarajoo S, El Adawi H, Zeini I, et al. Efficacy of probiotics-based interventions as therapy for inflammatory bowel disease: a recent update. Saudi J Biol Sci. 2022;29(5):3546\u201367.","journal-title":"Saudi J Biol Sci"},{"key":"1317_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.117089","volume":"240","author":"Y Chen","year":"2020","unstructured":"Chen Y, Zhang L, Hong G, Huang C, Qian W, Bai T, et al. Probiotic mixtures with aerobic constituent promoted the recovery of multi-barriers in DSS-induced chronic colitis. Life Sci. 2020;240:117089.","journal-title":"Life Sci"},{"key":"1317_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/nu13103319","author":"L Tong","year":"2021","unstructured":"Tong L, Zhang X, Hao H, Liu Q, Zhou Z, Liang X, et al. Lactobacillus rhamnosus GG derived extracellular vesicles modulate gut microbiota and attenuate inflammatory in DSS-induced colitis mice. Nutrients. 2021. https:\/\/doi.org\/10.3390\/nu13103319.","journal-title":"Nutrients"},{"issue":"5","key":"1317_CR44","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1007\/s00394-021-02503-5","volume":"60","author":"XF Zhang","year":"2021","unstructured":"Zhang XF, Guan XX, Tang YJ, Sun JF, Wang XK, Wang WD, et al. Clinical effects and gut microbiota changes of using probiotics, prebiotics or synbiotics in inflammatory bowel disease: a systematic review and meta-analysis. Eur J Nutr. 2021;60(5):2855\u201375.","journal-title":"Eur J Nutr"},{"key":"1317_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2020.116958","volume":"250","author":"P Li","year":"2020","unstructured":"Li P, Xiao N, Zeng L, Xiao J, Huang J, Xu Y, et al. Structural characteristics of a mannoglucan isolated from Chinese yam and its treatment effects against gut microbiota dysbiosis and DSS-induced colitis in mice. Carbohydr Polym. 2020;250:116958.","journal-title":"Carbohydr Polym"},{"issue":"1","key":"1317_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13020-025-01183-1","volume":"20","author":"S Zhang","year":"2025","unstructured":"Zhang S, Li B, Han X, Ruan L, Fu X, Chen Y, et al. Sanren decoction ameliorates ulcerative colitis by modulating gut microbiota and macrophage polarization to enhance intestinal barrier function. Chin Med. 2025;20(1):1\u201323.","journal-title":"Chin Med"},{"key":"1317_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1273407","volume":"14","author":"Y Zong","year":"2023","unstructured":"Zong Y, Meng J, Mao T, Han Q, Zhang P, Shi L. Repairing the intestinal mucosal barrier of traditional Chinese medicine for ulcerative colitis: a review. Front Pharmacol. 2023;14:1273407.","journal-title":"Front Pharmacol"},{"issue":"1","key":"1317_CR48","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3390\/nu15010139","volume":"15","author":"S Cheng","year":"2022","unstructured":"Cheng S, Li H, Huang Y, Su Y, Li Y, Jia A, et al. Lactobacillus gasseri JM1 isolated from infant feces alleviates colitis in mice via protecting the intestinal barrier. Nutrients. 2022;15(1):139.","journal-title":"Nutrients"},{"issue":"9","key":"1317_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1012541","volume":"20","author":"G Qian","year":"2024","unstructured":"Qian G, Zang H, Tang J, Zhang H, Yu J, Jia H, et al. Lactobacillus gasseri ATCC33323 affects the intestinal mucosal barrier to ameliorate DSS-induced colitis through the NR1I3-mediated regulation of E-cadherin. PLoS Pathog. 2024;20(9):e1012541.","journal-title":"PLoS Pathog"},{"key":"1317_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.590226","volume":"8","author":"X Chen","year":"2020","unstructured":"Chen X, Yu C, Kang R, Tang D. Iron metabolism in ferroptosis. Front Cell Dev Biol. 2020;8:590226.","journal-title":"Front Cell Dev Biol"},{"issue":"51","key":"1317_CR51","doi-asserted-by":"publisher","first-page":"32433","DOI":"10.1073\/pnas.2006828117","volume":"117","author":"JY Lee","year":"2020","unstructured":"Lee JY, Nam M, Son HY, Hyun K, Jang SY, Kim JW, et al. Polyunsaturated fatty acid biosynthesis pathway determines ferroptosis sensitivity in gastric cancer. Proc Natl Acad Sci U S A. 2020;117(51):32433\u201342.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1317_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20153683","author":"T Wang","year":"2019","unstructured":"Wang T, Fu X, Chen Q, Patra JK, Wang D, Wang Z, et al. Arachidonic acid metabolism and kidney inflammation. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20153683.","journal-title":"Int J Mol Sci"},{"key":"1317_CR53","doi-asserted-by":"publisher","first-page":"4246255","DOI":"10.1155\/2021\/4246255","volume":"2021","author":"W Gao","year":"2021","unstructured":"Gao W, Zhang T, Wu H. Emerging Pathological Engagement of Ferroptosis in gut diseases. Oxid Med Cell Longev. 2021;2021:4246255.","journal-title":"Oxid Med Cell Longev"},{"key":"1317_CR54","doi-asserted-by":"publisher","first-page":"9678625","DOI":"10.1155\/2022\/9678625","volume":"2022","author":"J Huang","year":"2022","unstructured":"Huang J, Zhang J, Ma J, Ma J, Liu J, Wang F, et al. Inhibiting Ferroptosis: a novel approach for ulcerative colitis therapeutics. Oxid Med Cell Longev. 2022;2022:9678625.","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"1317_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50454-2","volume":"15","author":"G Asantewaa","year":"2024","unstructured":"Asantewaa G, Tuttle ET, Ward NP, Kang YP, Kim Y, Kavanagh ME, et al. Glutathione synthesis in the mouse liver supports lipid abundance through NRF2 repression. Nat Commun. 2024;15(1):6152.","journal-title":"Nat Commun"}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-025-01317-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-025-01317-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-025-01317-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T04:08:56Z","timestamp":1769400536000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13020-025-01317-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,26]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1317"],"URL":"https:\/\/doi.org\/10.1186\/s13020-025-01317-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7844488\/v1","asserted-by":"object"}]},"ISSN":["1749-8546"],"issn-type":[{"value":"1749-8546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,26]]},"assertion":[{"value":"13 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal study protocol was approved by the Animal Care and Use Committee (ACUC) of [Nanjing University of Traditional Chinese Medicine], protocol number [ACU240404]. The study adhered to the guidelines set by the committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This is to confirm that the work has not been and will not be submitted simultaneously to another journal, in whole or in part; it reports previously unpublished work. If accepted, neither the paper itself nor substantial parts of it, will be published in the same form, in any language, without the consent of the publishers. The submitted version of the manuscript has been approved by all the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"52"}}